+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Fibrin degradation products (FDP) and fibrinolytic activity of blood in various acute and chronic diseases

Fibrin degradation products (FDP) and fibrinolytic activity of blood in various acute and chronic diseases

Folia Haematologica 103(3): 425-430

(PDF 0-2 workdays service: $29.90)

Accession: 038940172

Download citation: RISBibTeXText

PMID: 63429

Related references

Fibrin degradation products and fibrinolytic activity in most frequent renal diseases in children. Pediatria Polska 47(1): 49-54, 1972

Content of fibrinogen degradation products, soluble fibrin and the fibrinolytic activity of blood in myocardial infarct. Kardiologiia 19(8): 87-91, 1979

Soluble fibrin monomers complexes, fibrinolytic activity and fibrin degradation products in experimental hyperglycemia and hypoglycemia. Polskie Archiwum Medycyny Wewnetrznej 49(4): 337-343, 1972

Changes in fibrinogen, fibrin-fibrinogen degradation products and fibrinolytic activity during pregnancy, labor and the puerperium in pregnant women with chronic hypertension. Medicinski Arhiv 54(1): 29-31, 2000

Assessment of fibrin degradation products during fibrinolytic therapy for acute myocardial infarction. Circulation 74(5): 1027-1036, 1986

Increased fibrinolytic activity and fibrin degradation products after experimental intracerebral haemorrhage. Acta Neurologica Scandinavica 48(4): 403-415, 1972

Fibrin deposits in the glomeruli and fibrin/fibrinogen degradation products (FDP) in the blood and urine in some renal diseases. International Urology and Nephrology 14(1): 89-93, 1982

Enhancement of amidolytic activity on chromogenic substrate of strepto kinase plasminogen complex induced by fibrin degradation products comparison of potentiator activity between fibrinogen fibrinogen degradation products d or e and fibrin split products early and late stages. Haemostasis 11(SUPPL 1): 98, 1982

Relation between fibrin/fibrinogen degradation products in malignant fluids and the fibrinolytic activity of the peritoneum. Gan No Rinsho. Japan Journal of Cancer Clinics 32(15): 1945-1949, 1986

Fragments of urinary fibrin/fibrinogen degradation products and cross-linked fibrin degradation products in various renal diseases. Thrombosis Research 53(4): 367-377, 1989

Coagulation and Fibrinolytic System in Various Glomerular Diseases in Childhood: 2nd report A Study on the Origin of Urinary Fibrin/Fibrinogen Degradation Products (FDP). Pediatrics International 20(2): 49-50, 1978

Comparison of the potentiating effect of fibrinogen fibrinogen degradation products and fibrin degradation products on the amidolytic activity of the plasminogen strepto kinase complex improvement of plasminogen determination in biological samples by decreasing the influence of fibrin degradation products. Thrombosis & Haemostasis 50(1): 56, 1983

Fibrinolytic system, fibrinogen degradation products and soluble fibrin monomer complexes of renal venous and aortal blood. Experientia 25(9): 996-997, 1969

Serum crosslinked fibrin (XDP) and fibrinogen/fibrin degradation products (FDP) in disorders associated with activation of the coagulation or fibrinolytic systems. British Journal of Haematology 60(4): 715-722, 1985

Reactivity of soluble fibrin assays with plasmic degradation products of fibrin and in patients receiving fibrinolytic therapy. Thrombosis and Haemostasis 82(6): 1722-1729, 1999